1. CLINICAL SPECTRUM OF PRECURSOR B-CELL LYMPHOBLASTIC MALIGNANCIES: A LARGE COHORT STUDY OF 364 PEDIATRIC PATIENTS. (October 2022) Authors: Kroeze, E.; Bakker, M.; Boer, J.; Hagleitner, M.; Burkhardt, B.; Padilla, L.; Mori, T.; Attarbaschi, A.; Verdú-Amorós, J.; Pillon, M.; Anderzhanova, L.; Kabíčková, E.; Chiang, A.; Kebudi, R.; Mellgren, K.; Lasic, J.; Jazbec, J.; Meijerink, J.; Beishuizen, A.; Loeffen, J. Journal: Leukemia research Issue: Volume 121(2022)Supplement Page Start: S21 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Inactivation of KLF4 promotes T-cell acute lymphoblastic leukemia and activates the MAP2K7 pathway that can be targeted for therapy. (December 2016) Authors: Shen, Y.; Park, C.S.; Suppipat, K.; Mistretta, T.A.; Puppi, M.; Horton, T.; Rabin, K.; Meijerink, J.; Lacorazza, D. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S113 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗